Celalettin Üstün

9.8k total citations
147 papers, 3.0k citations indexed

About

Celalettin Üstün is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Celalettin Üstün has authored 147 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Hematology, 35 papers in Oncology and 31 papers in Immunology. Recurrent topics in Celalettin Üstün's work include Hematopoietic Stem Cell Transplantation (56 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (25 papers). Celalettin Üstün is often cited by papers focused on Hematopoietic Stem Cell Transplantation (56 papers), Acute Myeloid Leukemia Research (38 papers) and Acute Lymphoblastic Leukemia research (25 papers). Celalettin Üstün collaborates with scholars based in United States, Türkiye and France. Celalettin Üstün's co-authors include Daniel J. Weisdorf, David L. DeRemer, Anand P. Jillella, Kavita Natarajan, Kapil N. Bhalla, Jeffrey S. Miller, Warren Fiskus, Rekha Rao, Ramesh Balusu and Bruce R. Blazar and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Celalettin Üstün

139 papers receiving 3.0k citations

Peers

Countries citing papers authored by Celalettin Üstün

Since Specialization

Citations

This map shows the geographic impact of Celalettin Üstün's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celalettin Üstün with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celalettin Üstün more than expected).

Fields of papers citing papers by Celalettin Üstün

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celalettin Üstün. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celalettin Üstün. The network helps show where Celalettin Üstün may publish in the future.

Co-authorship network of co-authors of Celalettin Üstün

This figure shows the co-authorship network connecting the top 25 collaborators of Celalettin Üstün. A scholar is included among the top collaborators of Celalettin Üstün based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celalettin Üstün. Celalettin Üstün is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of patients with primary central nervous system lymphoma following CD19-targeted chimeric antigen receptor T-cell therapy 2024 ·Haematologica ·Santiago Mercadal, Kwang Woo Ahn, (unknown), (unknown), Praveen Ramakrishnan Geethakumari, Sanghee Hong, Adriana K. Malone, Hemant S. Murthy, Attaphol Pawarode, Alejandro Sica, Melhem Solh, Celalettin Üstün, Mazyar Shadman, Craig S. Sauter, Mehdi Hamadani, Alex F. Herrera, Catherine J. Lee	3
2	Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee 2024 ·Transplantation and Cellular Therapy ·Zainab Shahid, Aaron Etra, John E. Levine, Marcie Riches, Aliyah Baluch, Joshua A. Hill, Ryo Nakamura, Amir A. Toor, Celalettin Üstün, Jo‐Anne H. Young, Miguel‐Angel Perales, David J. Epstein, Hemant S. Murthy	3
3	Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts 2023 ·International Journal of Molecular Sciences ·Peter Valent, Cem Akin, Michel Arock, Karoline V. Gleixner, Hildegard Greinix, Olivier Hermine, Hans‐Peter Horny, (unknown), Alberto Órfão, Werner Rabitsch, Andreas Reiter, Axel Schulenburg, Karl Sotlar, Wolfgang R. Sperr, Celalettin Üstün	1
4	How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy? 2023 ·Blood Reviews ·Mark Juckett, Christopher E. Dandoy, Zachariah DeFilipp, Tamila L. Kindwall‐Keller, Stephen R. Spellman, Celalettin Üstün, (unknown), Daniel J. Weisdorf, William A. Wood, Mary M. Horowitz, Linda J. Burns, Nandita Khera	1
5	Post-transplantation cyclophosphamide is associated with increased bacterial infections 2023 ·Bone Marrow Transplantation ·Celalettin Üstün, Min Chen, Soyoung Kim, Jeffery J. Auletta, Marjorie Vieira Batista, Minoo Battiwalla, Jan Černý, Lohith Gowda, Joshua A. Hill, Hongtao Liu, Pashna N. Munshi, Sunita Nathan, Matthew D. Seftel, John R. Wingard, Roy F. Chemaly, Christopher E. Dandoy, Miguel‐Angel Perales, Marcie Riches, Genovefa A. Papanicolaou	4
6	Scedosporium infection disseminated “from toe to head” in allogeneic stem cell transplant recipient: a case report 2023 ·BMC Infectious Diseases ·(unknown), (unknown), Graeme N. Forrest, Rebecca S. LaRue, Sunita Nathan, Celalettin Üstün, (unknown)	2
7	Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients 2021 ·Transplant Infectious Disease ·(unknown), (unknown), Qing Cao, (unknown), (unknown), (unknown), Jo‐Anne H. Young, Timothy L. Pruett, Daniel J. Weisdorf, Celalettin Üstün	8
8	Presumed mast cell choroidal infiltrate in aggressive systemic mastocytosis 2020 ·American Journal of Ophthalmology Case Reports ·Tu M. Tran, (unknown), (unknown), José S. Pulido, Celalettin Üstün, Dara D. Koozekanani	0
9	Information Needs for Treatment Decision-making of Hematopoietic Cell Transplant Patients 65 Years or Older and Caregivers 2019 ·Journal of Cancer Education ·(unknown), Heather Moore, Jaime M. Preussler, Linda J. Burns, (unknown), Brett Glotzbecker, Shirley Johnson, (unknown), Lih‐Wen Mau, Elizabeth Murphy, Celalettin Üstün, (unknown), Ellen M. Denzen	7
10	Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up 2018 ·Biology of Blood and Marrow Transplantation ·Erica D. Warlick, Todd E. DeFor, Nelli Bejanyan, Shernan G. Holtan, Margaret L. MacMillan, Bruce R. Blazar, Kathryn E. Dusenbery, Mukta Arora, Veronika Bachanová, Sarah Cooley, Aleksandr Lazaryan, Philip B. McGlave, Jeffrey S. Miller, Armin Rashidi, Arne Slungaard, Gregory M. Vercellotti, Celalettin Üstün, (unknown), Daniel J. Weisdorf	8
11	Catheter-Related Thrombosis in Patients with Lymphoma or Myeloma Undergoing Autologous Stem Cell Transplantation 2018 ·Biology of Blood and Marrow Transplantation ·Livia Hegerova, (unknown), Qing Cao, (unknown), John Rogosheske, Mark T. Reding, Claudio G. Brunstein, Mukta Arora, Celalettin Üstün, Gregory M. Vercellotti, Veronika Bachanová	11
12	History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease‐negative first complete remission 2017 ·American Journal of Hematology ·Armin Rashidi, Michael A. Linden, Todd E. DeFor, Erica D. Warlick, Nelli Bejanyan, Sophia Yohe, Daniel J. Weisdorf, Celalettin Üstün	15
13	Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source 2017 ·Biology of Blood and Marrow Transplantation ·Sharat Damodar, Ryan Shanley, Margaret L. MacMillan, Celalettin Üstün, Daniel J. Weisdorf	22
14	Alternative Donor Transplantation for Older Patients with Acute Myeloid Leukemia in First Complete Remission: A Center for International Blood and Marrow Transplant Research-Eurocord Analysis 2014 ·Biology of Blood and Marrow Transplantation ·Daniel Weisdorf, Mary Eapen, Annalisa Ruggeri, Mei-Jie Zhang, Xiaobo Zhong, Claudio G. Brunstein, Celalettin Üstün, Vanderson Rocha, Éliane Gluckman	60
15	Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over Time 2012 ·Biology of Blood and Marrow Transplantation ·Celalettin Üstün, Jiří Slabý, Ryan Shanley, Jan Vydra, Angela R. Smith, John E. Wagner, Daniel J. Weisdorf, Jo‐Anne H. Young	49
16	Laparoscopic Appendectomy in a Patient with Acute Myelogenous Leukemia with Neutropenia 2007 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Celalettin Üstün	12
17	What Is the Optimum Number of CD34 ⁺ Peripheral Blood Stem Cells for an Autologous Transplant? 2004 ·Stem Cells and Development ·Anand P. Jillella, Celalettin Üstün	59
18	Infectious Complications in Patients Receiving Mobilization Chemotherapy for Autologous Peripheral Blood Stem Cell Collection 2003 ·Journal of Hematotherapy & Stem Cell Research ·Anand P. Jillella, Celalettin Üstün, (unknown), (unknown), (unknown), Andre M. Kallab, (unknown), (unknown), Abdullah Kutlar, (unknown), Russell Burgess	11
19	Rituximab Provides Durable Remission in a Patient with Refractory Aggressive Diffuse B-cell Lymphoma Failing Salvage Chemotherapy 2002 ·Leukemia & lymphoma ·(unknown), Celalettin Üstün, Andre M. Kallab, (unknown), Anand P. Jillella	1
20	Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital 2000 ·Bone Marrow Transplantation ·Önder Arslan, (unknown), Mutlu Arat, Harika Çelebi, Muhıt Özcan, Günhan Gürman, Celalettin Üstün, Taner Demirer, Hamdi Akan, Osman İlhan, Nahıde Konuk, Meral Beksaç, A. Uysal, Hakan Koç	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact